Summary
This Form 8-K filing by AmerisourceBergen Corporation (now Cencora, Inc.) on July 12, 2007, announces a significant corporate action: the establishment of a new, publicly traded company, PharMerica Corporation. This new entity will be formed through the spin-off and subsequent combination of the institutional pharmacy businesses of both AmerisourceBergen and Kindred Healthcare, Inc. Investors holding AmerisourceBergen or Kindred stock as of the close of business on July 20, 2007, will receive shares in PharMerica Corporation, which is set to commence trading on the New York Stock Exchange under the ticker symbol "PMC" on July 31, 2007. The filing also reveals the nine-member Board of Directors for the newly formed PharMerica Corporation, signaling a key step towards its operational launch.
Key Highlights
- 1AmerisourceBergen and Kindred Healthcare are spinning off their institutional pharmacy businesses.
- 2The spin-offs will combine to form a new entity named PharMerica Corporation.
- 3PharMerica Corporation will be a separately listed company on the New York Stock Exchange (NYSE).
- 4The ticker symbol for the new company on the NYSE will be "PMC".
- 5The record date for shareholders to be entitled to receive PharMerica shares is July 20, 2007.
- 6The distribution of PharMerica shares to eligible shareholders is scheduled for July 31, 2007.
- 7The filing announces the appointment of the nine-member Board of Directors for PharMerica Corporation.